Andrew ratz, ph.d., joins neurocrine biosciences as senior vice president of drug development, delivery and device

San diego , jan. 23, 2025 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced that andrew ratz, ph.d., has joined the company as senior vice president of drug development, delivery and device.

NBIX Ratings Summary

NBIX Quant Ranking